Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Julian
Relationship:  
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   34    
Direct Shares   1,028,565    

Indirect Shares

   246,186,665      
Direct Value   $74,191,640    

Indirect Value

   $16,503,068,893      
Total Shares   247,215,230      
Total Value   $16,577,260,533      


Incyte Corp $32,925,824 Neurogene $16,634 Acadia Pharmaceuticals Inc $3,143,891 Aceragen, Inc $16,666 Mirati Therapeutics, Inc. $16,084 Beigene Ltd $3,047,349 Seagen Inc $10,649,448 Alexion Pharmaceuticals Inc $24,083,248 Kiniksa Pharmaceuticals, Ltd. $292,496 Incyte Corp $32,925,824 Neurogene $16,634 Acadia Pharmaceuticals Inc $3,143,891 Aceragen, Inc $16,666 Mirati Therapeutics, Inc. $16,084 Beigene Ltd $3,047,349 Seagen Inc $10,649,448 Alexion Pharmaceuticals Inc $24,083,248 Kiniksa Pharmaceuticals, Ltd. $292,496
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    46   
    7    

     Stock price went up :
    23   
    7    
     Stock price went down :
    23   
    0    
   
     Gain/Loss Ratio :
   0.0   
   7.0   
     Percentage Gain/Loss :
   11.8%
 80.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synageva BioPharma Corp GEVA 10% Owner 2003-09-26 0 2011-11-02 144,082    Premium*  
            Innoviva Inc INVA Director 2005-12-13 0 2004-10-04 33,839    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2004-10-13 0 2011-06-30 4,045,398    Premium*  
            Incyte Corp INCY 2024-05-07 559,963 2024-05-07 33,496,391    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2019-08-29 0 2019-08-29 9,262,659    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 2009-01-23 0 2009-01-23 2,258    Premium*  
            Viropharma Inc VPHM 10% Owner 0 2011-12-14 9,840,469    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2009-10-19 5,264,782    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2012-01-27 0    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 2011-08-22 0 2012-02-10 557,211    Premium*  
            XOMA Corporation XOMA Former 10% owner 0 2015-07-22 90,538    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 3,540,015    Premium*  
            Neurogene NGNE Director 2020-07-07 4,520 2020-07-07 3,501,691    Premium*  
            Acadia Pharmaceuticals Inc ACAD 2024-05-29 205,752 2024-05-29 39,349,751    Premium*  
            Invitae Corp NVTA 10% Owner 2018-03-28 0 2018-03-28 7,553,553    Premium*  
            Aceragen, Inc ACGN 10% Owner 2019-07-01 43,858 2019-07-01 4,290,995    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM Former 10% owner 2017-10-05 0 2017-10-05 1,878,242    Premium*  
            Mirati Therapeutics, Inc. MRTX 10% Owner 2017-11-08 274 2017-11-08 35,999    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 2018-01-17 0 2018-01-19 58,131    Premium*  
            Beigene Ltd BGNE Director, 10% Owner 2021-06-16 20,838 2021-06-16 11,703,086    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2021-05-14 46,557 2021-05-14 43,309,073    Premium*  
            Alexion Pharmaceuticals Inc ALXN Director 2020-05-14 131,963 2020-05-14 7,940,623    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA Director, 10% Owner 2019-06-06 14,840 2019-06-06 2,700,597    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2018-10-09 0 2021-09-30 13,526,726    Premium*  
            Atreca Inc BCEL 10% Owner 2019-06-24 0 2019-06-24 3,223,030    Premium*  
            Igm Biosciences, Inc. IGMS Director, 10% Owner 2019-09-20 0 2021-01-27 2,895,306    Premium*  
            Prelude Therapeutics Inc PRLD Director, 10% Owner 0 2021-01-27 9,252,951    Premium*  
            DBV Technologies SA DBVT Director, 10% Owner 0 2021-01-01 4,286,038    Premium*  
            Talis Biomedical Corp TLIS Director, 10% Owner 0 2021-02-17 7,003,766    Premium*  
            Aeglea Biotherapeutics, Inc. AGLE Director 0 2021-02-23 3,410,106    Premium*  
            Tscan Therapeutics, Inc. TCRX Director 2021-07-20 0 2021-07-20 1,320,302    Premium*  
            Entrada Therapeutics, Inc. TRDA 10% Owner 0 2021-12-14 4,704,419    Premium*  
            Bicycle Therapeutics Ltd BCYC 0 2024-04-18 6,449,320    Premium*  
            Immunocore Holdings Adr IMCR 0 2024-05-28 1,515,318    Premium*  
* Premium Members only  

Records found :    498         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 12 of 20
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
GHDX Genomic Health Inc Director   –       •       •   2007-03-01 4 B $17.77 $307,443 I/I 16,983 541,572 2.25 -
INCY Incyte Corp Director   –       •      –    2007-08-03 4 B $4.83 $308,859 I/I 64,003 1,746,161 2.1 -
INCY Incyte Corp Director   –       •       •   2009-09-24 4 A $6.75 $339,485 I/I 50,294 189,909 0 -
PCYC Pharmacyclics Inc 10% Owner   –       –       •   2011-11-28 4 B $13.32 $343,702 I/I 25,764 185,797 1.5 -
INCY Incyte Corp Director   –       •      –    2007-11-15 4 B $8.62 $369,431 I/I 42,843 2,113,285 2.1 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2008-04-17 4 B $13.28 $371,601 I/I 27,982 2,273,322 1.5 -
PCYC Pharmacyclics Inc 10% Owner   –       –       •   2012-01-20 4 OE $15.00 $373,500 I/I 24,900 7,911,578 0 -
INCY Incyte Corp Director   –       •       •   2007-12-19 4 B $10.61 $373,755 I/I 35,234 2,592,218 2.25 -
INCY Incyte Corp Director   –       •      –    2007-11-19 4 B $8.22 $385,151 I/I 46,836 2,193,278 2.1 -
GHDX Genomic Health Inc Director   –       •      –    2007-02-12 4 B $17.89 $389,019 I/I 21,742 1,253,292 2.1 -
KOD Kodiak Sciences Inc. Director   –       •       •   2020-03-17 4 B $38.99 $389,850 I/I 10,000 10,570,083 2.25 %
PCYC Pharmacyclics Inc 10% Owner   –       –       •   2011-11-29 4 B $14.12 $395,098 I/I 27,871 213,668 1.5 -
PCYC Pharmacyclics Inc 10% Owner   –       –       •   2011-08-22 4 B $9.93 $395,528 I/I 39,710 41,519 1.5 -
INCY Incyte Corp Director   –       •       •   2007-12-17 4 B $10.60 $395,777 I/I 37,354 2,535,723 2.25 -
PCYC Pharmacyclics Inc 10% Owner   –       –       •   2012-01-25 4 B $18.43 $399,626 I/I 21,565 365,338 1.5 -
PCYC Pharmacyclics Inc 10% Owner   –       –       •   2012-01-24 4 B $17.86 $404,958 I/I 22,555 343,773 1.5 -
INCY Incyte Corp Director   –       •       •   2007-12-10 4/A B $9.54 $408,906 I/I 42,843 2,370,010 2.25 -
INCY Incyte Corp Director   –       •      –    2007-12-10 4 B $9.54 $408,906 I/I 42,843 2,370,010 2.1 -
SGEN Seagen Inc Director   –       •       •   2018-05-18 4 A $56.77 $420,098 I/I 7,400 45,829,686 0 -
INCY Incyte Corp Director   –       •      –    2007-11-14 4 B $8.53 $427,238 I/I 50,099 2,070,442 2.1 -
INCY Incyte Corp Director   –       •      –    2007-08-01 4 B $4.95 $444,588 I/I 89,883 1,664,712 2.1 -
SGEN Seagen Inc Director   –       •       •   2020-04-23 4 OE $12.76 $446,600 I/I 35,000 45,860,149 0 -
INCY Incyte Corp Director   –       •      –    2007-11-21 4 B $8.12 $454,801 I/I 56,010 3,040,128 2.1 -
GHDX Genomic Health Inc Director   –       •       •   2005-10-04 4 B $12.00 $464,208 I/I 38,684 181,478 2.25 -
OCRX Ocera Therapeutics Inc 10% Owner   –       –       •   2012-03-13 4 B $2.96 $470,382 I/I 159,015 3,449,177 1.5 -
  498  Records found
  1   2   3   4   5   6   7   8   9   10   11   12  13   14   15   16   17   18   19   20      
  Page 12 of 20  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us